|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.48 EUR | -1.98% |
|
+1.95% | -8.20% |
| 02-11 | Formycon, Lotus Sign License Deal for Keytruda Biosimilar in Asia-Pacific Region | MT |
| 02-11 | Swiss stocks - Factors to watch on February 11 | RE |
EPS & Dividend: Formycon AG
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.5387 | -1.218 | 2.59 | 4.72 | -7.18 | -1.814 | -0.4431 | 1.965 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 53.00 | 59.00 | 86.50 | 56.40 | 53.10 | 23.95 | 23.95 | 23.95 |
| Nbr of stocks (in thousands) | 10,000 | 11,047 | 15,130 | 16,039 | 17,657 | 17,664 | 17,664 | - |
| Announcement Date | 17/05/21 | 18/05/22 | 27/04/23 | 25/04/24 | 27/03/25 | - | - | - |
1EUR in Million2EUR
Estimates
Upcoming events: Formycon AG
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -13.2x | 1.02x | 9.11x | ||
| 0.97% | 1.07% | 35.47x | 3.63x | 5.16x | ||
| -.--% | -.--% | 108.36x | 9.72x | 6.91x | ||
| 0.3% | 0.3% | 63.6x | 3.03x | 12.97x | ||
| -.--% | -.--% | 25.05x | 4.75x | 2.68x | ||
| -.--% | -.--% | -17.54x | 11.94x | 5009.7x | ||
| 0.98% | 1.15% | 24.86x | 2.21x | 2.05x | ||
| -.--% | -.--% | -53.36x | 6222.39x | 15.66x | ||
| -.--% | -.--% | -37.26x | 49.62x | 14.17x | ||
| - | - | - | - | - | ||
| Average | 0.25% | 0.28% | 15.11x | 700.92x | 564.27x | |
| Weighted average by Cap. | 0.33% | 0.36% | 36.24x | 408.17x | 455.79x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















